Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IOSIF KALENDAREV

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1457720963
CMS profile
10418951
Location
NEW YORK, NY

General Payments · PY2021–2024

$2,375.87

  • Reported across 93 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$995.25

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $995.25 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $108.27 5
PY2022 $515.31 22
PY2023 $757.04 31
PY2024 $995.25 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $80.54 05/10/2024 Food and Beverage Undisputed 01/23/2026 1107432781 CMS
Blueprint Medicines Corporation $32.28 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147449948 CMS
Blueprint Medicines Corporation $32.46 03/20/2024 Food and Beverage Undisputed 01/23/2026 1147449960 CMS
Blueprint Medicines Corporation $35.99 04/15/2024 Food and Beverage Undisputed 01/23/2026 1147449962 CMS
Blueprint Medicines Corporation $30.37 05/21/2024 Food and Beverage Undisputed 01/23/2026 1147449964 CMS
Blueprint Medicines Corporation $32.10 07/24/2024 Food and Beverage Undisputed 01/23/2026 1147449970 CMS
Blueprint Medicines Corporation $38.42 08/15/2024 Food and Beverage Undisputed 01/23/2026 1147449986 CMS
Blueprint Medicines Corporation $33.19 10/07/2024 Food and Beverage Undisputed 01/23/2026 1147449988 CMS
Blueprint Medicines Corporation $34.87 11/11/2024 Food and Beverage Undisputed 01/23/2026 1147449996 CMS
Blueprint Medicines Corporation $29.81 12/02/2024 Food and Beverage Undisputed 01/23/2026 1147450000 CMS
Celgene Corporation $34.27 12/16/2024 Food and Beverage Undisputed 01/23/2026 1101081651 CMS
GlaxoSmithKline, LLC. $24.57 03/06/2024 Food and Beverage Undisputed 01/23/2026 1116119818 CMS
GlaxoSmithKline, LLC. $29.93 06/13/2024 Food and Beverage Undisputed 01/23/2026 1116429520 CMS
GlaxoSmithKline, LLC. $17.58 08/12/2024 Food and Beverage Undisputed 01/23/2026 1116422407 CMS
GlaxoSmithKline, LLC. $21.40 09/20/2024 Food and Beverage Undisputed 01/23/2026 1116389692 CMS
Kite Pharma, Inc. $34.83 06/10/2024 Food and Beverage Undisputed 01/23/2026 1128609729 CMS
Kite Pharma, Inc. $31.19 09/09/2024 Food and Beverage Undisputed 01/23/2026 1128609731 CMS
Novartis Pharmaceuticals Corporation $24.09 02/05/2024 Food and Beverage Undisputed 01/23/2026 1086986716 CMS
Novartis Pharmaceuticals Corporation $17.14 02/05/2024 Food and Beverage Undisputed 01/23/2026 1086986718 CMS
Novartis Pharmaceuticals Corporation $23.70 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086986720 CMS
Novartis Pharmaceuticals Corporation $23.62 03/19/2024 Food and Beverage Undisputed 01/23/2026 1086986722 CMS
Novartis Pharmaceuticals Corporation $14.99 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086986724 CMS
Novartis Pharmaceuticals Corporation $24.88 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086986726 CMS
Novartis Pharmaceuticals Corporation $11.70 07/19/2024 Food and Beverage Undisputed 01/23/2026 1086986728 CMS
Novartis Pharmaceuticals Corporation $15.59 08/19/2024 Food and Beverage Undisputed 01/23/2026 1086986730 CMS
Novartis Pharmaceuticals Corporation $24.62 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086986732 CMS
Novartis Pharmaceuticals Corporation $16.83 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086986734 CMS
Rigel Pharmaceuticals, Inc. $40.46 11/18/2024 Food and Beverage Undisputed 01/23/2026 1145206679 CMS
SERVIER PHARMACEUTICALS LLC $17.74 04/08/2024 Food and Beverage Undisputed 01/23/2026 1147266342 CMS
SERVIER PHARMACEUTICALS LLC $19.76 07/22/2024 Food and Beverage Undisputed 01/23/2026 1147266340 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.95 06/12/2024 Food and Beverage Undisputed 01/23/2026 1144977964 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.16 07/17/2024 Food and Beverage Undisputed 01/23/2026 1144977966 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.16 09/18/2024 Food and Beverage Undisputed 01/23/2026 1144977968 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.07 11/06/2024 Food and Beverage Undisputed 01/23/2026 1144977970 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.99 12/11/2024 Food and Beverage Undisputed 01/23/2026 1144977972 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.